These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8443816)

  • 1. Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin.
    Bhuyan BK; Smith KS; Kelly RC; Adams EG; Abraham I; Sampson KE
    Cancer Res; 1993 Mar; 53(6):1354-9. PubMed ID: 8443816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.
    Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP
    Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK
    Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
    Smith KS; Folz BA; Adams EG; Bhuyan BK
    Cancer Chemother Pharmacol; 1995; 35(6):471-82. PubMed ID: 7533669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects.
    Bhuyan BK; Smith KS; Adams EG; Wallace TL; Von Hoff DD; Li LH
    Cancer Chemother Pharmacol; 1992; 30(5):348-54. PubMed ID: 1505072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustards.
    Robson CN; Alexander J; Harris AL; Hickson ID
    Cancer Res; 1986 Dec; 46(12 Pt 1):6290-4. PubMed ID: 3779647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant.
    Butryn RK; Smith KS; Adams EG; Abraham I; Stackpole J; Sampson KE; Bhuyan BK
    Cancer Chemother Pharmacol; 1994; 34(1):44-50. PubMed ID: 7513620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Cancer Res; 1990 Aug; 50(15):4453-7. PubMed ID: 2369722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation spectra induced by adozelesin in the supF gene of human XP-A fibroblasts.
    Lee SY; Pfeifer GP; Lee CS
    Arch Pharm Res; 2010 Apr; 33(4):633-6. PubMed ID: 20422374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese hamster pleiotropic multidrug-resistant cells are not radioresistant.
    Mitchell JB; Gamson J; Russo A; Friedman N; DeGraff W; Carmichael J; Glatstein E
    NCI Monogr; 1988; (6):187-91. PubMed ID: 3352763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of a novel chemotherapeutic agent, Adozelesin, in gynecologic-cancer cell lines.
    Nguyen HN; Sevin BU; Averette H; Perras J; Hightower R; Ramos R; Donato D; Penalver M
    Cancer Chemother Pharmacol; 1992; 30(1):37-42. PubMed ID: 1586978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
    Lee CS; Pfeifer GP; Gibson NW
    Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence selectivity of DNA alkylation by adozelesin and carzelesin.
    Yoon JH; Lee CS
    Arch Pharm Res; 1998 Aug; 21(4):385-90. PubMed ID: 9875464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of CHO cells expressing P-glycoprotein to cyclopropylpyrroloindole (CPI) alkylating agents.
    Zsido TJ; Beerman TA; Meegan RL; Woynarowski JM; Baker RM
    Biochem Pharmacol; 1992 Apr; 43(8):1817-22. PubMed ID: 1349478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo mutagenesis induced by CC-1065 and adozelesin DNA alkylation in a transgenic mouse model.
    Monroe TJ; Mitchell MA
    Cancer Res; 1993 Dec; 53(23):5690-6. PubMed ID: 8242625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
    Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.